Repaglinide

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 57237-157
  • Package NDC 57237-157-01
  • Package NDC 57237-157-05
  • Application number ANDA203820
  • SPL ID 641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4
  • SPL set ID d7673e22-0dbb-4395-ad60-943d249203a1
  • UNII 668Z8C33LU
  • RxCUI 200256
  • RxCUI 200257
  • RxCUI 200258

What the source publishes

Labeler
Rising Pharma Holdings, Inc.
Active ingredients
Repaglinide
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:57237-157_641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4
{
  "name": "Repaglinide",
  "splId": "641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4",
  "labels": [
    {
      "setId": "d7673e22-0dbb-4395-ad60-943d249203a1",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7673e22-0dbb-4395-ad60-943d249203a1",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d7673e22-0dbb-4395-ad60-943d249203a1"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Rising Pharma Holdings, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE (57237-157-01)",
      "package_ndc": "57237-157-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20140122"
    },
    {
      "sample": false,
      "description": "500 TABLET in 1 BOTTLE (57237-157-05)",
      "package_ndc": "57237-157-05",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20140122"
    }
  ],
  "productId": "57237-157_641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "57237-157",
  "deaSchedule": null,
  "genericName": "Repaglinide",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "REPAGLINIDE",
      "strength": ".5 mg/1"
    }
  ],
  "applicationNumber": "ANDA203820",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20140122",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175428",
      "N0000175448"
    ],
    "upc": [
      "0357237157015",
      "0357237158012",
      "0357237159019"
    ],
    "unii": [
      "668Z8C33LU"
    ],
    "rxcui": [
      "200256",
      "200257",
      "200258"
    ],
    "spl_set_id": [
      "d7673e22-0dbb-4395-ad60-943d249203a1"
    ],
    "pharm_class_epc": [
      "Glinide [EPC]"
    ],
    "pharm_class_moa": [
      "Potassium Channel Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "Rising Pharma Holdings, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:57237-157_641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4"